Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial (Q34580726)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q55186651)
(Q47710870)
(Q58664238)
(Q87723651)
(Q88733900)
(Q56376448)
(Q63372147)
(Q115787230)
(P304) 2161-2170
(P407) (Q1860)
(P433) 9580
(P478) 369
(P577) Friday, June 1, 2007
(P921) (Q42824827)
(Q134808)
(Q69999790)
(P1433) (Q939416)
(P1476) "Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial" (language: en)
(P2093) David Jenkins
Paulo Naud
Song-Nan Chow
Henry C Kitchener
Xavier Castellsague
Newton S de Carvalho
Diane M Harper
James A Hedrick
Unnop Jaisamrarn
Genara Am Limson
Marc Dionne
Bart Spiessens
Pascal Peeters
Susan L Wieting
Matti O Lehtinen
Gary Dubin
HPV PATRICIA study group
(P2860) (Q29617514)
(Q36610447)
(Q40227526)
(Q29616213)
(Q29618731)
(Q45552005)
(Q28236008)
(Q35999045)
(Q36238689)
(Q35073297)
(Q36891915)
(Q52602533)
(Q64112091)
(Q34068782)
(Q40788937)
(Q44574224)
(Q81499715)
(Q73414358)
(Q42038224)
(Q39683911)
other details
description scientific article

External Links